FDBusiness.com

Lipogen expand facilities and build new phospholipids R&D center

 Breaking News
  • Nestlé Inaugurates New Nescafé Dolce Gusto Production in Vietnam Nestlé has inaugurated a new Nescafé Dolce Gusto capsule production line in Dong Nai Province, Vietnam. The site will process an expected 2,500 tons of coffee per year (equivalent to 130 million capsules), using high quality coffee beans from Vietnam. This volume is expected to increase in the coming years. The investment reflects Nestlé’s clear focus on high-growth, [...]...
  • Pink Lemonade Yogurt? Arla Brings Indulgence to New Markets Arla Foods is to expand its successful Finnish brand, Ihana, into new markets with the premium yogurt range being launched in Denmark and the UK. Meaning ‘wonderful’ in Finnish, Ihana was launched through an extensive brand launch in 2016 in Finland with an iconic new design. Indulgence is one of the few areas in growth within [...]...
  • Process Components Announces Kemutec Expansion into Netherlands Process Components has announced the expansion of subsidiary company Kemutec in Europe, with the long-established manufacturing brand opening a new office in the Netherlands. The move forms a key part of its global strategy to extend its global territories, significantly grow its revenues and create new jobs. Kemutec has more than three decades’ worth of heritage in [...]...
  • Packaging Automation Supports the Reduction in Plastic Packaging Waste With the launch of the UK Plastics Pact to address the impact plastic waste is having on the environment, retailers and manufacturers are more conscious of single use and non-recyclable plastics and want to cater for the green consumer. The industry is turning to various kinds of eco-friendly packaging with the aim of reducing plastic [...]...
  • Glanbia Cheese Joint Venture to Build New €130 Million Mozzarella Cheese Facility Glanbia Cheese, the joint venture business between Glanbia plc and Leprino Foods, plans to build a new, world-class mozzarella cheese manufacturing facility in Portlaoise, County Laois, Ireland. A site for the new facility has been identified at the recently established Togher National Industrial Estate in Portlaoise. A total of €130 million will be invested in [...]...

Lipogen expand facilities and build new phospholipids R&D center

November 16
09:27 2015

lipogenLipogen Ltd. is expanding its production facilities and building a new phospholipids research and development center.

The development is in response to a 50 percent jump in sales of brain and stress health solutions in Q1-Q3 2015.

Lipogen invested US$2.6 million in building two additional production lines for PhosphatidylSerine (PS) and Phosphatidic Acid (PA). The company also added 10,000 sq ft to its facilities to double production capabilities for PS and PA.

Upgrades include automated controlled processing to reduce production costs through improved production traceability, and implementing new safety methods, allowing Lipogen to produce its all-natural, non-GMO, solvent-free ingredients in accordance with the highest industry standards.

The PS market is forecast to grow significantly due to developments of new applications plus a growing demand in emerging markets, such as India and China.

Data from Nutrition Business Journal put the US cognitive health market at $1.2 billion by 2014 and estimates the market will hit almost $1.5 billion by 2020.

“Increasing demand for our brain health and stress management ingredients pushed us to establish a new growth strategy for our PS and PA product line,” says David Rutenberg, CEO of Lipogen. “The phospholipids market is expanding from traditional brain function support to new brain health concepts, including: stress management, cortisol control, ADHD mitigation, sports nutrition and more.”

Lipogen continues to research and develop new cognitive and stress management solutions based on proprietary technology and enzymatic process. The advanced, well-equipped phospholipids R&D center was designed to support product development and product research at Lipogen facilities. The company has appointed Abraham Rutenberg as VP and R&D manager. In addition, Lipogen expanded its headquarters, appointing Ariel Gordon as VP Business Development manager to develop new segments and markets for Lipogen’s leading brands.

“I’m excited to welcome Abraham Rutenberg and Ariel Gordon to our team,” said Mr Rutenberg. “They will lead Lipogen to the next level via high-impact growth—not only in the dietary supplements industry, but also in the food, beverage and pharmaceuticals industries. Lipogen is committed to producing pure, high-quality products with minimal damage to the environment. We’ve initiated a long-term sustainability strategy for our complete product line.”

With 25 years of specializing in natural phospholipid research, development and production, Lipogen guarantees its customers ingredient systems that are supported by the highest level of scientific data, technical quality and safety to meet the growing demand for natural cognitive health solutions.

About Author

admin

admin

Related Articles



Food & Drink Business Conference & Exhibition 2016

Upcoming Events

  • September 5, 2018Int'l Food Products and Processing Technologies Exhibition (WorldFood Istanbul)
  • September 15, 2018iba
  • September 25, 2018PPMA Show 2018
  • September 27, 2018Int'l Fruit Show (eurofruit)
AEC v1.0.4

find food jobs

The Magazine

F&D Business Preferred Suppliers

New Subscriber





Subscribe Here



Advertisements